Messages in brief
Electronic Application Forms eAF - new version 1.23
New versions of the electronic Application Forms (eAF v. 1.23) and related documents are available via the EMA-website (http://esubmission.ema.europa.…
Recall of drugs containing the active ingredient valsartan from the Chinese manufacturer Zhejiang Huahai Pharmaceutical
A batch-related recall of medicines containing valsartan, the active ingredient of which was produced by the Chinese manufacturer Zhejiang Huahai…
Request for barrier-free provision of information for use
The Federal Office for Safety in Health Care (BASG) was obligated within the framework of a conciliation procedure pursuant to Section 14 of the…
Fluoroquinolones: summary of the public hearing of 13.06.2018.
The EuropeanMedicines Agency (EMA) held the public consultation on the impact of potential adverse reactions to fluoroquinolones, a group of…
100. EMA Managementboard-Meeting
On the occasion of the 100th meeting of the EMA Management Board, it was not only a matter of efficiently dealing with an extensive agenda, but also…
Announcement new registration page for eServices goes online with 20.6.2018
As of 6/20/2018, you will find a redesigned interface when logging in to PHAROS eServices. Please take note of this in your daily work. The login data…
Save the date - "Pharmacovigilance update"
Red Hand Letter on Leaking Syringes in Some GSK Vaccines
Important information about leaking syringes with some Glaxo SmithKline vacc ines Affected vaccines: Boostrix, Boostrix Polio, Engerix-B, Havrix,…
Fluoroquinolones: public hearing on 13.06.2018
The EuropeanMedicines Agency (EMA) has launched registration for the public consultation. The consultation will take place on 13/06/2018 at the EMA…
A little more careful than others... How AGES ensures safe hemophilia medicines
World Hemophilia Day 2018
Hemophilia is a congenital, lifelong increased bleeding tendency in which a deficiency or complete absence of certain…
